Steven Perrin - Net Worth and Insider Trading
Steven Perrin Net Worth
The estimated net worth of Steven Perrin is at least $4,340 dollars as of 2024-12-26. Steven Perrin is the President of Eledon Pharmaceuticals Inc and owns about 1,000 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $4,340. Details can be seen in Steven Perrin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Perrin has not made any transactions after 2022-11-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven Perrin
Steven Perrin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven Perrin owns 1 companies in total, including Eledon Pharmaceuticals Inc (ELDN) .
Click here to see the complete history of Steven Perrin’s form 4 insider trades.
Insider Ownership Summary of Steven Perrin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2022-11-23 | director & See Remarks |
Steven Perrin Latest Holdings Summary
Steven Perrin currently owns a total of 1 stock. Steven Perrin owns 1,000 shares of Eledon Pharmaceuticals Inc (ELDN) as of November 23, 2022, with a value of $4,340.
Latest Holdings of Steven Perrin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2022-11-23 | 1,000 | 4.34 | 4,340 |
Holding Weightings of Steven Perrin
Steven Perrin Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven Perrin has made a total of 1 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the acquisition of 1,000 shares on November 23, 2022, which cost Steven Perrin around $2,600.
Insider Trading History of Steven Perrin
- 1
Steven Perrin Trading Performance
GuruFocus tracks the stock performance after each of Steven Perrin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Perrin is -3.98%. GuruFocus also compares Steven Perrin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Perrin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven Perrin's insider trading performs compared to the benchmark.
Performance of Steven Perrin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.39 | | | | | |
| Relative Return to S&P 500(%) | 2.14 | | | | | |
Steven Perrin Ownership Network
Steven Perrin Owned Company Details
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Steven Perrin is the director & See Remarks of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & Chief Executive Officer David-alexandre C Gros , and CHIEF FINANCIAL OFFICER Paul Sean Little .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
Steven Perrin Mailing Address
Above is the net worth, insider trading, and ownership report for Steven Perrin. You might contact Steven Perrin via mailing address: C/o Anelixis Therapeutics, Inc., 1500 District Avenue, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
